Faculty

Institution

Unit

Venue

Angela L. Tyner

Professor

University of Illinois Chicago

Affiliations

College of Medicine

Department of Biochemistry and Molecular Genetics

Angela L. Tyner is currently serving as a College Of Medicine Professor at University of Illinois Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Angela L. Tyner

University of Illinois Chicago

Professor

You can click a keyword to filter the displayed items

tumor biology cell biology cancer biology molecular biology pharmacology gene expression cancer research genetics oncology cell signaling medicinal research oncogenes signal transduction receptor tyrosine kinases molecular cancer cell regulation cancer genetics mammalian biology protein science colorectal cancer membrane biology molecular regulation cancer treatment molecular physiology cell death cancer genomics cancer cells enzyme inhibition digestive diseases molecular and cellular biology cellular physiology transcription regulation gastrointestinal oncology molecular cell biology biological chemistry apoptosis protein function protein phosphorylation liver physiology cell cycle cellular biology gene function tumor targeting protein expression cutaneous biology gene regulation tumor suppressors signaling pathways vascular biology in vivo systems drug targeting cancer growth mammalian physiology rna biology developmental science functional modification mitochondrial function differential expression colon cancer host response cell lineage cell growth transgenic mice prostate tumor cells cell cycle progression gastrointestinal tract linoleic acid mouse small intestine transcriptional regulation negative regulator differentiation-specific expression critical regulator cell cycle arrest dietary compound luteolin rna binding ability posttranscriptional regulation immunology carcinogenesis epithelial biology prostate cancer

Notable Scholarly Works

Notable Federal Grants

Collaborators

Impaired Activation of Succinate-Induced Type 2 Immunity and Secretory Cell Production in the Small Intestines of Ptk6−/− Male Mice. Cell Death and Disease (2024)

Katarina VlajicWenjun BieMilica B. GilicAngela L. Tyner

immunologycell deathpathogenesisreproductive immunologycellular immune responsessmall intestinescell signalingdevelopmental immunologyinnate immune systemmolecular biologyimmune responsessecretory cell productionimpaired activationimmunity (medicine)specific resistancecell biology

Appearance of Tuft Cells During Prostate Cancer Progression. Oncogene (2023)

Katarina VlajicHannah Pennington KlugerWenjun BieBradley J. MerrillLarisa NonnAndre Kajdacsy-BallaAngela L. Tyner

neurologycancer researchgeneticsurologytuft cellsoncologyoncogenesprostate cancer progressioncancer biologyprostate cancer

Mo1221 Protein Tyrosine Kinase 6 (Ptk6) Differentially Regulates Type 2 Immunity in the Intestine in a Sex-Dependent Manner. Gastroenterology (2023)

Katarina VlajicWenjun BieAngela L. Tyner

immunologydigestive diseasesmedicineclinical gastroenterologypharmacologyhematologyvenereologymucosal immunologymolecular gastroenterologyadaptive immune systemvirologysex-dependent mannergastroenterologyimmune responseshepatology

Protein Tyrosine Kinase 6 Regulates Activation of Src Kinase. Journal of Biological Chemistry (2022)

Wanian M. AlwanianKatarina VlajicWenjun BieAndre Kajdacsy-BallaAngela L. Tyner

pharmacologycell signalingreceptor tyrosine kinasessrc kinasesignal transductionbiochemistry

Protein Tyrosine Kinase 6 Signaling in Prostate Cancer.. PubMed (2020)

Wanian M AlwanianAngela L Tyner

neurologymedicineprotein functioncancer biologycancer researchcell signalingurologyreceptor tyrosine kinasessignal transductionprotein scienceprostate cancerprotein tyrosine

Targeting Protein Tyrosine Kinase 6 in Cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020)

Milica B. GilicAngela L. Tyner

immunologytumor targetingpharmacologycancer researchreceptor tyrosine kinasescancer immunotherapyoncologydrug targetingcancer treatmentcancer biologyprotein sciencetumor biologybiochemistry

Vemurafenib Inhibits Active Ptk6 in Pten -Null Prostate Tumor Cells. Molecular Cancer Therapeutics (2019)

Darren J. WozniakBen HitchinsonMilica B. GilicWenjun BieVadim GaponenkoAngela L. Tyner

cancer researchmolecular cancermolecular biologyprostate canceroncologycancer treatmenttumor biology

Vemurafenib Inhibits Active Ptk6 in Pten-Null Prostate Tumor Cells. Mol Cancer Ther (2019)

radiation oncologymolecular cancertherapeutic targetsprostatic diseaseanti-cancer agentsprostate canceroncogenescancer cellstumor biology

Pten is a Protein Phosphatase That Targets Active Ptk6 and Inhibits Ptk6 Oncogenic Signaling in Prostate Cancer. Nature Communications (2017)

Darren J. WozniakAndre Kajdacsy-BallaVirgilia MaciasSusan Ball-KellMorgan L. ZennerWenjun BieAngela L. Tyner

cell signalingoncogenic signalingprostate cancernaturetumor targetingprotein phosphatasemolecular cancercancer genomicsurologydrug targetingcell regulationtumor biologycarcinogenesissignaling pathwaysenzyme inhibitionpharmacologymolecular biologyoncogenesmedicinal researchsignal transduction

Abstract 197: Phospholipids Regulate the Localization and Oncogenic Potential of Protein Tyrosine Kinase 6 in Prostate Cancer. Cancer Research (2016)

Darren J. WozniakBen HitchinsonWenjun BieVadim GaponenkoAngela L. Tyner

neurologycarcinogenesispharmacologycell regulationcancer researchtumor biologyurologycancer genomicsmolecular regulationoncogenic potentialoncologymedicinal researchcancer treatmentcancer biologyprostate cancer

1
2
3
4
5
12
10 / page

Angela L. Tyner

Professor

University of Illinois Chicago

Affiliations

College of Medicine

Department of Biochemistry and Molecular Genetics

Angela L. Tyner is currently serving as a College Of Medicine Professor at University of Illinois Chicago.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Angela L. Tyner

University of Illinois Chicago

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Impaired Activation of Succinate-Induced Type 2 Immunity and Secretory Cell Production in the Small Intestines of Ptk6−/− Male Mice. Cell Death and Disease (2024)

Katarina VlajicWenjun BieMilica B. GilicAngela L. Tyner

Appearance of Tuft Cells During Prostate Cancer Progression. Oncogene (2023)

Katarina VlajicHannah Pennington KlugerWenjun BieBradley J. MerrillLarisa NonnAndre Kajdacsy-BallaAngela L. Tyner

neurologycancer researchgeneticsurologytuft cellsoncologyoncogenesprostate cancer progressioncancer biologyprostate cancer

Mo1221 Protein Tyrosine Kinase 6 (Ptk6) Differentially Regulates Type 2 Immunity in the Intestine in a Sex-Dependent Manner. Gastroenterology (2023)

Katarina VlajicWenjun BieAngela L. Tyner

Protein Tyrosine Kinase 6 Regulates Activation of Src Kinase. Journal of Biological Chemistry (2022)

Wanian M. AlwanianKatarina VlajicWenjun BieAndre Kajdacsy-BallaAngela L. Tyner

pharmacologycell signalingreceptor tyrosine kinasessrc kinasesignal transductionbiochemistry

Protein Tyrosine Kinase 6 Signaling in Prostate Cancer.. PubMed (2020)

Wanian M AlwanianAngela L Tyner

neurologymedicineprotein functioncancer biologycancer researchcell signalingurologyreceptor tyrosine kinasessignal transductionprotein scienceprostate cancerprotein tyrosine

Targeting Protein Tyrosine Kinase 6 in Cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020)

Milica B. GilicAngela L. Tyner

immunologytumor targetingpharmacologycancer researchreceptor tyrosine kinasescancer immunotherapyoncologydrug targetingcancer treatmentcancer biologyprotein sciencetumor biologybiochemistry

Vemurafenib Inhibits Active Ptk6 in Pten -Null Prostate Tumor Cells. Molecular Cancer Therapeutics (2019)

Darren J. WozniakBen HitchinsonMilica B. GilicWenjun BieVadim GaponenkoAngela L. Tyner

cancer researchmolecular cancermolecular biologyprostate canceroncologycancer treatmenttumor biology

Vemurafenib Inhibits Active Ptk6 in Pten-Null Prostate Tumor Cells. Mol Cancer Ther (2019)

radiation oncologymolecular cancertherapeutic targetsprostatic diseaseanti-cancer agentsprostate canceroncogenescancer cellstumor biology

Pten is a Protein Phosphatase That Targets Active Ptk6 and Inhibits Ptk6 Oncogenic Signaling in Prostate Cancer. Nature Communications (2017)

Darren J. WozniakAndre Kajdacsy-BallaVirgilia MaciasSusan Ball-KellMorgan L. ZennerWenjun BieAngela L. Tyner

Abstract 197: Phospholipids Regulate the Localization and Oncogenic Potential of Protein Tyrosine Kinase 6 in Prostate Cancer. Cancer Research (2016)

Darren J. WozniakBen HitchinsonWenjun BieVadim GaponenkoAngela L. Tyner

1
2
3
4
5
12
10 / page

Similar Faculty Members

Nissim Hay

Institution

University of Illinois Chicago

cancer biology

cancer research

Scott W. Hiebert

Institution

Vanderbilt University

nascent transcription

oncogene

Pradeep K. Dudeja

Institution

University of Illinois Chicago

gastroenterology

cell biology

Albert Fornace

Institution

Georgetown University

molecular biology

radiation oncology

James R. Goldenring

Institution

Vanderbilt University

gastrointestinal oncology

gastroenterology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Enrique Rozengurt

Institution

University of California, Los Angeles

cell biology

pharmacology

Srinivasan Dasarathy

Institution

Case Western Reserve University

metabolic disorder

hepatotoxicity

Sarah Spiegel

Institution

Virginia Commonwealth University

signaling pathway

cancer cell

Similar Faculty Members

Nissim Hay

Institution

University of Illinois Chicago

cancer biology

cancer research

Scott W. Hiebert

Institution

Vanderbilt University

nascent transcription

oncogene

Pradeep K. Dudeja

Institution

University of Illinois Chicago

gastroenterology

cell biology

Albert Fornace

Institution

Georgetown University

molecular biology

radiation oncology

James R. Goldenring

Institution

Vanderbilt University

gastrointestinal oncology

gastroenterology

Harold L. Moses

Institution

Vanderbilt University

oncogene

molecular cancer

Robert J. Coffey, M.D

Institution

Vanderbilt University

gi neoplasia

oncogene

Enrique Rozengurt

Institution

University of California, Los Angeles

cell biology

pharmacology

Srinivasan Dasarathy

Institution

Case Western Reserve University

metabolic disorder

hepatotoxicity

Sarah Spiegel

Institution

Virginia Commonwealth University

signaling pathway

cancer cell